Comajoan von Arend, Pau (Date of defense: 2019-12-18)
Recombinant tissue plasminogen activator (rt-PA) is currently the only FDA-approved drug for the treatment of acute ischaemic stroke. However, the application of this therapy is limited to <5-7% of ...
616.1 - Pathology of the circulatory system, blood vessels. Cardiovascular complaints (1)